# A Study In Patients With Advanced Solid Tumor

> **NCT00726752** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Axitinib (AG-013736)

## Key facts

- **NCT ID:** NCT00726752
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2012-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726752, "A Study In Patients With Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00726752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*